{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:48:01Z","timestamp":1783028881395,"version":"3.54.6"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.anl.2023.11.008","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T16:00:58Z","timestamp":1701964858000},"page":"379-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy, safety, and tissue penetration of solithromycin in Japanese patients with otorhinolaryngological infections"],"prefix":"10.1016","volume":"51","author":[{"given":"Yuichi","family":"Kurono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyo","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yamatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2875-8368","authenticated-orcid":false,"given":"Satoshi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2023.11.008_bib0001","unstructured":"FDA Drug Safety Communications: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. 2016. Available from: https:\/\/www.fda.gov\/media\/119537\/download."},{"key":"10.1016\/j.anl.2023.11.008_bib0002","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1128\/AAC.00860-10","article-title":"Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis","volume":"54","author":"Llano-Sotelo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anl.2023.11.008_bib0003","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jiac.2020.06.014","article-title":"A novel macrolide, solithromycin suppresses mucin overexpression induced by Pseudomonas aeruginosa LPS in airway epithelial cells","volume":"26","author":"Kawamoto","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.anl.2023.11.008_bib0004","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1128\/AAC.00840-10","article-title":"Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptors","volume":"54","author":"Bertrand","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anl.2023.11.008_bib0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.toxlet.2010.02.005","article-title":"Telithromycin blocks neuromuscular transmission and inhibits nAChR currents in vitro","volume":"194","author":"Liu","year":"2010","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.anl.2023.11.008_bib0006","unstructured":"Guidelines for clinical evaluation of antibacterial drugs. PSEHB\/PED Notification No. 1023-3 Oct. 23, 2017. Available from: https:\/\/www.pmda.go.jp\/files\/000234279.pdf."},{"key":"10.1016\/j.anl.2023.11.008_bib0007","series-title":"Handbook of clinical pharmacology and therapeutics","first-page":"320","article-title":"Chapter VIII, clinical evaluation of drug efficacy by disease, 14. Evaluation of efficacy of antiinfection drugs, C Otolaryngological diseases","author":"Baba","year":"1988"},{"key":"10.1016\/j.anl.2023.11.008_bib0008","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-tenth edition M07-A10. Wayne, PA:CLSI; 2015."},{"key":"10.1016\/j.anl.2023.11.008_bib0009","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; M100S, 26th Edition. Wayne, PA:CLSI; 2016."},{"key":"10.1016\/j.anl.2023.11.008_bib0010","series-title":"Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria","year":"2016"},{"key":"10.1016\/j.anl.2023.11.008_bib0011","unstructured":"Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard-eighth edition M11-A8. Wayne, PA:CLSI; 2012."},{"key":"10.1016\/j.anl.2023.11.008_bib0012","first-page":"29","article-title":"Clinical evaluation methods for new antimicrobial agents to treat respiratory infections v2. The Japan Society of Chemotherapy","volume":"60","year":"2012","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.anl.2023.11.008_bib0013","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7248\/jjrhi.49.143","article-title":"[Guideline for management of acute Rhinosinusitis]","volume":"49","author":"Yamanaka","year":"2010","journal-title":"Jpn J Rhinol"},{"key":"10.1016\/j.anl.2023.11.008_bib0014","unstructured":"Sanofi Aventis K.K. Ketek Tablets (Telithromycin) 300mg package insert. Revised in April 2011 (v12). Japanese."},{"key":"10.1016\/j.anl.2023.11.008_bib0015","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jiac.2020.05.020","article-title":"The seventh nationwide surveillance of six otorhinolaryngological infectious diseases and the antimicrobial susceptibility patterns of the isolated pathogens in Japan","volume":"26","author":"Suzuki","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.anl.2023.11.008_bib0016","first-page":"1563","article-title":"Promotion of appropriate use of antibacterial agents and development of new antibacterial agents for otorhinolaryngology head and neck surgery infections","volume":"125","author":"Hotomi","year":"2022","journal-title":"Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho Tokyo"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814623001955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814623001955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:41:57Z","timestamp":1759952517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814623001955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0385814623001955"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2023.11.008","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety, and tissue penetration of solithromycin in Japanese patients with otorhinolaryngological infections","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2023.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}